Download Full Volume - United States Renal Data System

BPREVALENCE OF REPORTED ESRD
Reference section B
Table Table B.1 B.1 (continued)
Point prevalent counts of of reported ESRD patients: U.S. only, with unknowns dropped
patients
patients
alive
alive
on
on
December
December
31
31
of
of
each
each
year,
year,
by
by
demographic
demographic
characteristics
characteristics
& primary
primary
diagnosis
diagnosis
322
1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003
0-4 409 402 402 422 392 410 431 476 474 465 455
5-9 744 769 791 810 881 860 879 867 894 915 938
10-14 1,320 1,417 1,491 1,545 1,533 1,633 1,663 1,742 1,768 1,855 1,808
15-19 2,537 2,649 2,788 2,876 2,987 3,047 3,172 3,206 3,289 3,335 3,483
20-29 14,731 15,029 15,256 15,623 15,871 16,162 16,262 16,290 16,308 16,219 16,246
30-39 33,571 35,400 36,589 37,649 38,422 39,243 40,059 40,737 41,057 41,349 41,479
40-49 43,228 47,268 51,511 55,287 58,286 61,799 64,803 67,761 70,135 72,317 74,421
50-59 44,275 48,853 52,552 57,244 62,789 68,858 75,025 80,903 86,962 92,269 97,688
60-64 24,811 26,746 28,705 30,739 32,882 35,402 37,546 39,631 41,921 44,951 48,070
65-69 27,031 29,292 30,931 33,055 34,762 36,450 38,317 40,040 41,966 43,708 45,627
70-79 39,708 44,639 48,479 53,097 57,864 61,846 65,450 68,728 70,932 74,006 76,017
80+ 12,553 14,314 15,990 17,961 20,099 22,298 24,538 27,378 29,704 32,426 34,819
0-19 5,010 5,237 5,472 5,653 5,793 5,950 6,145 6,291 6,425 6,570 6,684
20-44 69,672 73,198 76,324 79,207 81,686 84,235 86,384 87,939 89,147 89,886 90,691
45-64 90,944 100,098 108,289 117,335 126,564 137,229 147,311 157,383 167,236 177,219 187,213
65-74 50,800 55,844 59,316 63,601 67,630 71,079 74,420 77,711 80,823 83,991 86,964
75+ 28,492 32,401 36,084 40,512 45,095 49,515 53,885 58,435 61,779 66,149 69,499
Male 131,949 143,610 153,598 165,158 176,813 188,776 200,418 211,726 222,097 233,252 243,340
Female 112,969 123,168 131,887 141,150 149,955 159,232 167,727 176,033 183,313 190,563 197,711
White 155,560 168,342 178,829 191,179 203,304 215,560 228,072 240,527 251,506 262,669 273,057
Black 78,951 86,555 93,384 100,570 107,614 115,079 121,209 126,945 132,171 137,981 143,584
Native American 3,086 3,408 3,734 4,022 4,302 4,688 5,025 5,288 5,574 5,779 5,926
Asian 7,321 8,473 9,538 10,537 11,548 12,681 13,839 14,999 16,159 17,386 18,484
†Hispanic 28,226 31,219 34,351 37,712 41,387 44,868 48,463 52,078
†Non-Hispanic 278,082 295,549 313,657 330,433 346,372 360,542 375,352 388,973
Diabetes 71,141 80,193 89,221 99,211 109,277 118,995 127,702 137,002 145,158 153,311 160,453
Hypertension 65,111 71,286 74,154 78,021 81,964 86,312 90,752 94,788 98,707 103,124 107,654
Glomerulonephritis 48,413 51,637 54,400 57,347 59,991 62,720 65,176 67,178 69,063 70,953 72,498
Cystic kidney 12,174 12,981 13,743 14,413 15,113 16,012 16,871 17,708 18,456 19,260 20,068
Other urologic 7,288 7,632 8,455 9,265 10,010 10,673 11,490 12,054 12,523 13,093 13,531
Other cause 26,820 28,534 30,631 32,538 34,334 36,473 38,332 40,219 41,781 43,456 45,205
Unknown cause 11,290 12,019 12,362 12,976 13,519 14,154 14,950 15,725 16,490 17,189 17,949
Missing disease 2,681 2,496 2,519 2,537 2,560 2,669 2,872 3,085 3,232 3,429 3,693
All 244,918 266,778 285,485 306,308 326,768 348,008 368,145 387,759 405,410 423,815 441,051
Patients dropped 5,034 5,502 6,081 6,822 7,366 7,936 8,469 9,182 9,751 10,493 11,906
The prevalent cohorts are determined at the time of ESRD initiation without applying the 60-day stable modality rule.
Age is calculated as of December 31.
U.S. only; patients of unknown age or gender, or of other or unknown race, are excluded so that rates can be calculated properly.
†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1996 have therefore been left blank.